Cargando…

Consensus protocol for the emergency reversal of coumarin-induced anticoagulation

Detalles Bibliográficos
Autores principales:	Dolan, G, Bevan, D, Giangrande, P, Hampton, K, Hay, C, Ludlam, C, McVerry, B, Pasi, K, Winter, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098493/ http://dx.doi.org/10.1186/cc3406

Ejemplares similares

Four-factor prothrombin complex concentrate (Beriplex® P/N) is superior to three-factor prothrombin complex concentrate for reversal of coumarin anticoagulation
por: Herzog, E, et al.
Publicado: (2015)

Reversal of oral anticoagulation with prothrombin complex concentrate (Octaplex)
por: Riess, H, et al.
Publicado: (2007)

Prothrombin complex concentrate use in surgical patients: a retrospective analysis of efficacy and safety for coumarin reversal and bleeding management
por: Schick, KS, et al.
Publicado: (2008)

Reversal of edoxaban-induced anticoagulation by the four-factor prothrombin complex concentrate Beriplex(® )in a rabbit model
por: Herzog, E, et al.
Publicado: (2014)

Ion-exchange resin anticoagulation: experimental data of a novel extracorporeal regional anticoagulation technique
por: Zanella, A, et al.
Publicado: (2015)

Initial anticoagulation strategy for extracorporeal cardiopulmonary resuscitation patients
por: Iwashita, Y, et al.
Publicado: (2014)

Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005)

In a trauma experimental pig model prothrombin complex concentrates and a specific antidote (idarucizumab) are effective to reverse the anticoagulant effects of dabigatran
por: Grottke, O, et al.
Publicado: (2014)

Emergency Reversal of Anticoagulation
por: Yee, Jennifer, et al.
Publicado: (2019)

Anticoagulation Management With Coumarinic Drugs in Chilean Patients
por: Nieto, Elena, et al.
Publicado: (2019)

Multicenter prospective observational study on safety and efficacy of regional citrate anticoagulation in CVVHD in the presence of liver failure: the Liver Citrate Anticoagulation Threshold Study (L-CAT)
por: Slowinski, T, et al.
Publicado: (2011)

Bedside anti-Xa measurement for therapeutic assessment of a prophylactic anticoagulation regimen
por: Dewulf, B, et al.
Publicado: (2013)

Efficacy of non-specific hemostatic agents for reversal of prophylactic apixaban levels
por: Schmidt, K, et al.
Publicado: (2015)

Anticoagulant effect of prothrombin complex concentrates: a whole blood in vitro study
por: Scharbert, G, et al.
Publicado: (2011)

Coumarin derivatives from Ainsliaea fragrans and their anticoagulant activity
por: Lei, Liang, et al.
Publicado: (2015)

Monitoring anticoagulation during extracorporeal membrane oxygenation in patients with acute respiratory failure
por: Panigada, M, et al.
Publicado: (2013)

Achieving consensus over the assessment of clinical signs in eczema trials
por: Thomas, Kim S, et al.
Publicado: (2015)

Intramural esophagic hematoma secondary to coumarinic anticoagulation: a case report
por: Quintero, Álvaro M, et al.
Publicado: (2009)

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
por: Makino, S, et al.
Publicado: (2015)

P02.51. Acupuncture treatment for hospitalized patients on anticoagulant therapy- a safety study
por: Miller, C, et al.
Publicado: (2012)

Developing juvenile localized scleroderma (jLS) consensus treatment regimens for comparative effectiveness studies
por: Li, Suzanne C, et al.
Publicado: (2012)

Regional citrate anticoagulation in high-volume continuous venovenous hemodialysis
por: Kalb, R, et al.
Publicado: (2011)

Primary bivalirudin anticoagulation for patients with an implantable ventricular assist device
por: Pieri, M, et al.
Publicado: (2014)

Use of anticoagulation and D-dimer levels in patients with acute heart failure
por: Bittencourt, MI, et al.
Publicado: (2005)

Failure to correct the international normalized ratio in patients with anticoagulant-related major bleeding is associated with increased 90-day mortality
por: Menzin, J, et al.
Publicado: (2011)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Dynamics of the dosage of citrate-calciuminfusion regimens as anticoagulation in continuous venovenous hemodiafiltration
por: Marin Mateos, H, et al.
Publicado: (2015)

Multicenter consensus development of a checklist for lung injury prevention
por: Litell, JM, et al.
Publicado: (2012)

P05.47. Yoga for musculoskeletal conditions: a Delphi survey to establish international consensus of core intervention components
por: Ward, L, et al.
Publicado: (2012)

Regional citrate anticoagulation with a low-concentration solution in predilution-postdilution CVVH
por: Pistolesi, V, et al.
Publicado: (2012)

Citrate anticoagulation realized as CVVHD using a newly designed dialysate solution
por: Morgera, S, et al.
Publicado: (2006)

Bivalirudin or heparin: which anticoagulation strategy for critically ill cardiac surgery patients?
por: Pappalardo, F, et al.
Publicado: (2014)

Blood transfusion requirements and filter longevity with regional citrate anticoagulation compared with heparin
por: Burford, E, et al.
Publicado: (2015)

Topoisomerase II isoforms are required for HIV-1 reverse transcription
por: Sunnam, Lokeswara Balakrishna, et al.
Publicado: (2012)

Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antibacterial effects in murine pneumococcal pneumonia
por: Boogaard, F van den, et al.
Publicado: (2009)

Heme oxygenase-1 reverses HIV-1 Tat activity: prospects for AIDS prevention
por: Cueno, ME, et al.
Publicado: (2012)

Prothrombin complex concentrate restores haemostasis in a dabigatran anticoagulated polytrauma pig model
por: Honickel, M, et al.
Publicado: (2014)

Thromboelastography may detect hypercoagulation in early sepsis and improve anticoagulation during extracorporeal treatments
por: Turani, F, et al.
Publicado: (2015)

Pharmacogenetics in the Management of Coumarin Anticoagulant Therapy: The Way Forward or an Expensive Diversion?
por: Greaves, Mike
Publicado: (2005)

Results of the Consensus Finding Study Group on Autoantibodies (March 2003–March 2004)
por: Hamann, D, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_0s1bmmsmornt8e03d06c88fnpc